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Background: The high prevalence of Coxiella burnetii infection in dairy cattle herds recently reported and the
long survival time of the bacterium in the environment pose a risk to human and animal health that calls for the
implementation of control measures at herd level. This study presents the results of a 2-year vaccination program
with an inactivated phase I vaccine in a Spanish dairy herd naturally infected with C. burnetii. Calves older than
3 months and non-pregnant heifers and cows were vaccinated in April 2011 and the farm was subsequently visited
at a monthly basis for vaccination of recently calved cows and calves that reached the age of 3 months. Annual
booster doses were given to previous vaccinated animals as well. The effectiveness of the vaccine was assessed
in terms of level of C. burnetii shedding through milk and uterine fluids and environmental contamination as
determined by polymerase chain reaction (PCR).
Results: The percentage of shedder animals through uterine fluids and milk progressively decreased, and C. burnetii
DNA load in bulk-tank milk samples was low at the end of the study. The average seroconversion rate in not yet
vaccinated animals, which acted as control group, was 8.6% during the first year and 0% in the second year. DNA
of C. burnetii was found in aerosols and dust samples taken in the calving area only at the beginning of the study,
whereas slurry samples remained C. burnetii PCR positive for at least 18 months. Multiple Locus Variable number
tandem-repeat Analysis identified the same genotype in all C. burnetii DNA positive samples.
Conclusions: In the absence of any changes in biosecurity, the overall reduction of C. burnetii infection in animals
to 1.2% milk shedders and the reduced environment contamination found at the end of the study was ascribed
to the effects of vaccination together with the culling of milk shedders. Vaccination has to be planned as a
medium-long term strategy to suppress risks of re-infection.
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Coxiella burnetii is the causative agent of Q fever, a
zoonotic disease considered an emerging public health
problem, especially after the outbreak in the Netherlands,
where more than 4,000 human cases have been notified
since 2007 [1,2]. A broad range of animal species have been
identified as reservoirs of C. burnetii, though domestic ru-
minants are considered the most important source of infec-
tion for humans [3]. Infected animals shed bacteria through
milk, faeces, vaginal fluids and birth products [4,5] but milk* Correspondence: agarcia@neiker.net
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unless otherwise stated.is the main excretion route in cattle [5]. Inhalation of aero-
sols contaminated with extracellular forms of C. burnetii
shed by infected animals is the main route of infection for
humans and also for non-immune animals, especially when
environmental conditions are favorable for the spread of
bacteria [6,7].
The high prevalence of C. burnetii infection in dairy
herds reported in recent studies [8,9] and the long survival
capacity of this bacterium in the environment [10] call for
the implementation of control measures aimed at reducing
the exposure level at herd level. Control measures based on
treatment with antibiotics or vaccination have been imple-
mented. A recent study reported that antibiotics adminis-
tered to dairy cattle at the drying-off period significantlyLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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However, once infection is established in a herd, antibiotics
are not able to reduce bacterial load shed by infected
animals [11,12]. So when infection is established in herds and
animal shedders are contaminating the environment through
feces or vaginal excretions, the implementation of a
vaccination program is necessary to protect susceptible
animals from being infected. Vaccine composition (C. burnetii
in phase I or virulent, with complete lipopolysaccharide (LPS)
and C. burnetii in phase II or not virulent, with incomplete
LPS) determines their effectiveness with vaccines with phase I
C. burnetii being more effective than those using phase II
bacteria [13,14]. Previous studies reported the effectiveness of
vaccination in reducing the probability of a susceptible animal
becoming a shedder [15] and the C. burnetii shedding level
both in experimental and natural infections in sheep [16],
goats [13] and dairy cattle [11,17]. Taking into account the
overall benefits of vaccination, the aim of this study was to
monitor the progression of C. burnetii infection in a naturally
infected commercial dairy cattle herd along 2 years of
vaccination and culling of milk shedders by measuring
C. burnetiiDNA levels in the environment (air and dust from
animal premises and slurry samples) and progression of
bacterial shedding in animals.
Methods
Selected herd
At the end of 2010, C. burnetii infection was diagnosed
in a dairy cattle herd (n = 252) with an abortion rate of
4%. Fetuses and placentas were not available for labora-
torial analyses but presence of C. burnetii DNA was
confirmed in vaginal mucus from aborted and calving
cows (9/11 vaginal swabs) by polymerase chain reaction
(PCR). Enzyme-linked immunosorbent assay (ELISA)
was performed on sera of 17 cows and seroprevalence
against C. burnetii was determined to be 23.5% (4/17).
The distribution of C. burnetii was further investigated
based on these preliminary data. Hence, a bulk-tank milk
(BTM) sample, blood (sera) and faeces from all the ani-
mals in the herd and individual milk from all lactating
cows were collected (March 2011) and analyzed by indi-
vidual ELISA and/or PCR. Animals were classified into
two categories “infected” and “non-infected”. Individuals
with antibodies against C. burnetii and/or being PCR
positive were considered “infected” and otherwise
“non-infected”. A seroprevalence of 40% was found in
first calving cows, and 9% of animals shed C. burnetii
through milk and 0.4% through faeces. According to
the EFSA criteria [18], presence of C. burnetii DNA in
vaginal mucus of aborting cows and a herd seropreva-
lence of around 50% are indicative of active C. burnetii
infection. Therefore, and in agreement with the farmer,
a 2-year culling and vaccination plan was prepared and
implemented from April 2011 onwards. Biosecuritylevel was not changed during this period and herd
management continued as usual.
Spanish ethical guidelines (RD 1201/2005) and animal
welfare regulations were strictly respected. Experimental
work was officially approved by competent local authorities
on health and animal welfare (Bizkaiko Foru Aldundia,
Reference 10559, 3rd November 2010).
Vaccination strategy
To obtain optimal results from vaccination, recommen-
dations derived from a previous vaccination study [15]
were followed and the vaccine was applied to calves
older than three months of age and non-pregnant heifers
and cows. Individual data about age and reproductive
status were compiled for all animals. Thus, vaccination
started in April 2011 and, according to the manufacturer's
instructions, each animal was given 2 doses 3 weeks apart
of 4 ml of inactivated phase I vaccine (Coxevac, CEVA
Santé Animale, Libourne, France) subcutaneously in the
neck area using sterile single-use needles and syringes.
Each 4 ml vaccine dose contained purified phase I
C. burnetii corpuscular antigens (100 μg/ml) inactivated
by formaldehyde. After this initial vaccination in April
2011, the farm was visited at a monthly basis, and all
newly incorporated three month-old female calves, heifers
that reached age for their first artificial insemination and
all cows that calved within that month, received their first
dose of vaccine followed by the second dose 3 weeks later.
The target was to vaccinate all the animals in the herd
within one year. Annual booster doses were given to all
the animals before artificial insemination. Bull calves,
which were removed from their dams after colostrum in-
take and fed on artificial milk until being sold at 4 months
of age, were not vaccinated.
Considering that Q fever is a zoonosis, no control
group of non-vaccinated animals was left in the herd,
and all animals were vaccinated according to the proto-
col. Instead animals not yet vaccinated according to the
protocol, e.g. cows being pregnant at the beginning at
the study, served as controls until they were vaccinated.
Sampling strategy
Serum samples were taken from animals prior to vac-
cination at the monthly visits to the farm along the
first year (April 2011-March 2012) to compare sero-
logical results (presence/absence of antibodies against
C. burnetii) with previous results obtained in March
2011 (seroconversion rate). Similarly, in April 2012
sera were taken from all the animals in the herd to
evaluate seroconversions occurring in not yet vacci-
nated animals during the second year of the study
(April 2012-March 2013). C. burnetii shedding in re-
cently calved cows was assessed by PCR of uterine fluid
samples taken immediately after calving.
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milk, BTM samples were collected monthly and individual
milk samples were collected from all milking cows every
6 months to evaluate changes in the percentage of animal
shedders.
To determine environmental contamination with C.
burnetii, samples collected included slurry sampled at a
monthly basis, air (aerosols) sampled every 6 months
using a Sartorius air sampler (Air Sampler, MD8 airscan,
Goettingen, Germany) at a flow rate of 100 l/min for
10 min and collecting particles in gelatine filters, and
dust collected from different animal premises surfaces
(swabs) every 6 months. Air and dust samples were
collected from the calving, breeding, and milking cows’
resting areas. In each sampling, 2 air samples and a
maximum of 10 dust samples were collected per area.
Laboratory analyses
Serological analyses
BTM, individual milk and serum samples were tested for
the presence of antibodies against C. burnetii using a
commercial indirect ELISA according to manufacturer’s
instructions (LSIVET Ruminant Milk/Serum Q Fever
kit; Laboratoire Service International, Lissieu, France).
The antigen used was isolated from domestic ruminants
at INRA, Nouzilly (France). A cocktail of antigen phases
I and II was used in this assay to detect total anti-C.
burnetii immunoglobulin G antibodies (IgG). The
sample-to-positive control (S/P) ratio was calculated as
follows: S/P = (OD sample – OD NC)/(OD PC – OD
NC), where OD sample = optical density of the sample,
OD NC = optical density of the negative control, and
OD PC = optical density of the positive control. The
results were expressed as an index: S/P × 100.
In the case of serum samples, S/P indices ≤40 were
considered negative, whereas indices >40 were indicative
of positive serum. On the other hand, milk samples with
S/P indices ≤30 were considered negative, whereas sam-
ples with indices >30 were considered positive for C.
burnetii antibodies.
PCR/qPCR analyses
Vaginal swabs, BTM samples, individual milk samples,
air (gelatine filters) and dust samples were subjected to
DNA extraction using the QIAmp DNA Blood Mini Kit
(Qiagen, Valencia, CA, USA) as previously described
[19,20]. Slurry samples were treated according to a
protocol adding 1 ml Phosphate Buffer Saline (Ambion,
Life Technologies, Alcobendas, Madrid, Spain) to 0.3 g
slurry, then vortexed for 3 min and centrifuged at 100 g
for 1 min. Finally, 175 μl of supernatant were subjected
to DNA extraction using the MagMax Total Nucleic
Acid Isolation Kit (Ambion) following the manufac-
turer’s instructions.A conventional PCR was carried out using primers
targeting a transposon-like IS1111 repetitive region of C.
burnetii as described elsewhere [21,22] adding a maximum
of 70 ng of DNA template to each reaction. Negative
controls were included every ten samples to rule out DNA
contamination. After a PCR positive result was confirmed,
the bacterial burden was quantified by quantitative real-
time PCR (qPCR) using primers previously described [23]
that target the IS1111 region, and adding a commercially
available TaqMan® Exogenous Internal Positive Control
(Applied Biosystems, Foster City, CA, USA). Reactions
were carried out using an ABI 7500 FAST thermocycler
(Applied Biosystems). For quantification, a standard
curve was included in each run with 10-fold serial
dilutions of the target gene IS1111. The standard linear
regression equation thus calculated was used to trans-
form qPCR raw data from Cq values to an estimate of
copy number per reaction tube. C. burnetii bacterial
load was expressed as log transformed value of bacteria
per gram, mililiter or swab, depending on the sample
type, and was calculated taking into account the
dilutions and volume transformations during sample
processing and the target gene copy number in the
Nine Mile reference strain (20 copies).C. burnetii genotyping
Vaginal mucus, individual milk, air, slurry and dust samples,
which had a positive qPCR result were submitted to
Multiple Locus Variable number tandem-repeat Analysis
(MLVA) to characterize the C. burnetii strains present in
the herd along the 2 years. Two multicolor multiplex PCR
assays were carried out targeting six microsatellite markers
containing either six or seven base pairs (bp) repeat units: 3
hexanucleotide repeat markers (Ms27, Ms28 and Ms34)
and 3 heptanucleotide repeat markers (Ms23, Ms24 and
Ms33). Primer sequences used were as described
before [24,25]. The procedure has been described in
detail elsewhere [26].Results
Animals included in the study
At the beginning of the study, the herd size was 252 ani-
mals (177 cows, 45 heifers and 30 calves). Along the two
years the census increased up to 289 animals with the in-
corporation of 165 heifers and the culling of 128 cows. Re-
productive problems, mastitis or trauma were the main
causes of culling. Therefore, a total of 392 animals were
vaccinated along the study. Based on the pre-vaccination
serostatus or PCR result, 311 of these animals were classi-
fied as being non-infected (98 cows, 22 heifers and 191
calves) while 81 were classified as infected (56 cows, 21
heifers and 4 calves).
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A total of 303 vaginal swabs collected from 217 cows
post-calving were analyzed. Vaginal shedding was only
detected from July to September 2011 and in January
2012 (Figure 1A). Five out of 217 cows shed C. burnetii
DNA through uterine fluids (2.3%), 3 of them being
first calving cows (3/104), a second calving cow (1/36)
and one cow with more than 3 calvings (1/77). Quanti-
fication of the bacterial load present in the 5 positive














































































































































































































































































































































































Bacterial load in BTM (Log bact/ml) ELISA (S/Px100)
Figure 1 Progression of Coxiella burnetii infection in the herd once
vaccination started (April 2011). (A) shedders through uterine fluids
after calving; (B) shedders through milk among milking cows; (C) C.
burnetii load (log bact/ml) and ELISA titre of antibodies (S/Px100 ratio)
against C. burnetii in bulk tank milk samples.(between 2.8 and 7.1 log bact/vaginal swab). Cows
shedding C. burnetii through uterine fluids did not
shed the organism again at the next calving.
Analysis of individual milk samples showed a gradual
decline in the percentage of C. burnetii milk shedders
throughout the study period (Figure 1B, Table 1). Before
vaccination started in March 2011, 9.0% (14/156) of lac-
tating cows were milk shedders. This prevalence was
gradually reduced to 1.2% (2/168) in April 2013. The
majority of C. burnetii milk shedders were cows with
more than 3 parturitions (Table 1) and from April 2012
onwards, no shedders were detected among younger
milking cows. The bacterial load of the positive milk
samples varied between 1.4 and 5.6 log bact/ml milk.
Along the study, 20 cows excreted C. burnetii DNA in
one milking at least. Milk of 16 of these was analyzed
more than one time. Eleven cows shed C. burnetii
intermittently and the 5 shed C. burnetii persistently.
The longest persistent excretion period recorded was
25 months (one cow). The reduced prevalence of milk
shedder cows along the study caused a significant de-
cline of C. burnetii bacterial burden in BTM at the end
of the study (Figure 1C).
Non-infected vaccinated animals were tested shortly
after calving (i.e. approx. 10 months after vaccination)
and none shed C. burnetii vaginally or through milk.
Seroconversion rates in animals prior to vaccination
Sera from parturient cows, i.e. just before vaccination
(n = 140) taken during the first study year were analyzed
and the serostatus was compared with results from
March 2011 to determine the seroconversion rate, i.e.
seronegative to seropositive. Twelve out of the 140 cows
seroconverted (8.6%). The highest rate of seroconversion
was found among cows at their first (6/30) or second
parturition (3/31), whereas cows with more than 3
calvings had a lower seroconversion rate (3/79). By April
2012 most of the cows in the herd had been vaccinated
and seroconversion was therefore only investigated in 16
animals during the second study year. None of these
seroconverted.
Kinetics of BTM antibodies are shown in Figure 1C.
An initial increase of C. burnetii antibody levels was
observed in BTM during the first six months of the
study where more than half of the animals were
vaccinated and the BTM antibody level reached a
maximum in September 2011. After this, a decrease
was observed and titers fluctuated slightly until the
end of the study.
Presence of C. burnetii DNA in the environment
At the beginning of the study, slurry (1/1; 1.5 log bact/g),
air samples (1/8; 2.7 log bact/ml) and dust from surfaces
taken in the calving area (1/23; 1.9 log bact/swab) were
Table 1 Progression in the percentage of milk shedders after vaccination (April 2011) in the different age groups of
milking cows in the different samplings





















1st calving 46 4.3 45 2.2 44 0.0 44 0.0 67 0.0
2nd calving 47 0.0 34 2.9 35 0.0 33 0.0 33 0.0
≥ 3 calvings 63 19.0 60 13.3 65 7.7 58 12.0 68 2.9
Total 156 9.0 139 7.2 144 3.5 135 5.2 168 1.2
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was only detected in slurry samples after this time. In July
2011, August 2011 and January 2012, positive slurry sam-
ples with C. burnetii DNA levels of 2.5, 1.7 and 1.1 log
bact/g, respectively, coincided with vaginal excretion in
post-parturient cows (Figure 1A). However, slurry samples
remained positive when vaginal excretion ceased in these
cows. A total of 44% of the analyzed slurry samples were
positive (11/25), the last positive being detected in Novem-
ber 2012 (Figure 2).
Genotyping of C. burnetii
A selection of samples (n = 38), which were positive by
qPCR with cycle threshold (Ct) values below 31 were ge-
notyped by MLVA. These included uterine fluids (n = 9),
individual milk (n = 25), BTM (n = 3) and slurry (n = 1).
Genotype I [26] was identified in all samples. The
genotype of the Nine Mile, RSA493 vaccine strain of C.
burnetii was not identified.
Discussion
Domestic ruminants are the main reservoir of C. burne-
tii. Infected animals shed the bacteria to the environ-
ment where they can persist for a long time [10] and
create aerosols that expose humans and animals to the
bacterium [3]. Vaccination against C. burnetii is considered
a good option to prevent infection of ruminants [13,15]
and consequently exposure to humans of C. burnetii. Thus,
recent studies confirmed the efficacy of vaccination in
terms of preventing C. burnetii shedding in uninfected
non-pregnant cows and calves [11,15]. The studySlurry
Aerosols
Dust surfaces
Figure 2 Samplings and results on the presence of Coxiella burnetii D
vaccination started (April 2011). Positive qPCR results are indicated with fillereported here, is the first to monitor the effectiveness of
vaccination during two consecutive years in a dairy cattle
farm naturally infected by C. burnetii regarding prevalence
of animal shedders and contamination of the environment.
Positive effects of vaccination were noticeable during
the second year since seroconversions were not
observed in susceptible animals thus indicating
that horizontal transmission was no longer at a signifi-
cant level. In addition to absence of seroconversion,
vaccination also seemed to reduce vaginal excretion as
uterine fluid samples were found negative by PCR
during the last 15 study months. A low percentage of
milk shedders and low bacterial load in BTM samples
were still found at the end of the study. The reduced
infections levels were reflected in all environmental
samples being negative to C. burnetii in the last six
months of the study period. Effectiveness of vaccination
was associated with prevention of susceptible non-infected
animals becoming C. burnetii shedders. In this sense, none
of the uninfected vaccinated animals shed C. burnetii
vaginally or through milk. This indicates an effective
protection of phase I vaccine and confirmed the results of
other authors who estimated that vaccinated, susceptible
animals have five times less probability to become
shedders than non-vaccinated animals [15].
An active culling strategy based on individual PCR re-
sults was not implemented in herd, but routine culling
of animals due to common conditions such as repro-
ductive problems, mastitis or trauma was performed.
Although this was done without regard to C. burnetii
status, culling of older cows and replacement withNA in environmental samples. The arrow indicates the time when
d stars and negative results with open stars.
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have reduced C. burnetii infection prevalence, excretion
rates and environmental contamination in the herd. The
two year culling rate in the herd was 44% (128/289
cows). Thirteen out of the 20 milk shedders had been
culled at the end of the study, including the five cows
that were considered persistently milk shedders. It is not
possible to differentiate the effects of vaccination
vs. culling, but this study reflects the usual herd
management procedures and in accordance with a previ-
ous study [27], it shows that vaccination and progressive
culling of shedder cows is an effective method to reduce
infection burden.
C. burnetii has previously been detected in aerosols of
infected environments associated to small ruminants
[28,29] but this is the first study to assess the presence
of C. burnetii in air and other environmental samples in
a dairy cattle herd. Presence of C. burnetii in air, dust
and slurry indicates the zoonotic risks associated with
these materials. Calvings in a dairy cattle farm occur
along the year, whereas in sheep flocks lambing is con-
centrated in a short period of time. As a result, after a Q
fever episode, heavily infected sheep farms showed high en-
vironmental contamination at lambing [19,20] with the
consequent risks for uninfected animals and humans. In
cattle, abortions due to Coxiella or bacterial shedding by in-
fected animals happen intermittently along the year and the
impact on air contamination with this zoonotic bacterium
be consequently diluted.
Although preventive phase I vaccination reduces the
risk of C. burnetii infection in uninfected animals [15],
vaccination of infected herds does not have an immedi-
ate effect. In this sense, a recent study demonstrated that
vaccination of already infected animals failed to re-
duce bacterial shedding [30]. The detection of positive
environmental samples after almost two years of
vaccination indicates that a long term vaccination and
culling strategy is needed to reduce the potential for
re-emergence of infection. This is in accordance with a
study that estimated the effectiveness of different models
of vaccination by using computer software and concluded
that vaccination programs should be implemented during
10 years to be truly effective [31].
Genotyping of C. burnetii isolated from clinical and
environmental samples has been helpful in identifying
the strains involved in active Q fever episodes and to
determine the ruminant sources involved in Q fever
outbreaks [25,26,32]. In the current study, C. burnetii
genotype I was identified in all samples. This genotype
has previously been isolated in bovine milk in several
European countries such as France, Holland, Portugal
and Switzerland [33] and it has also been found in
clinical samples of human placenta and heart valve in
France between 1994 and 1996 [34]. This indicates thepotential role of cattle in the domestic cycle of C. burne-
tii and the importance of implementing efficient farm-
based control measures.
Conclusions
The overall reduction of C. burnetii infection in animals
to 1.2% milk shedders and the reduced environment
contamination is ascribed to the effects of vaccination
together with the culling of milk shedders. Vaccination
has to be planned as a medium-long term strategy to
suppress risks of re-infection.
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